Inflammation and CFTR: Might Neutrophils be the Key in Cystic Fibrosis?
The aim of this hypothesis is to provide new insights into the still unclear mechanisms governing airway inflammation in cystic fibrosis. Although the genetic basis of cystic fibrosis as well as the molecular structure of cystic fibrosis transmembrane regulator (CFTR), the mutated protein which caus...
Saved in:
| Main Authors: | V. Witko-Sarsat, I. Sermet-Gaudelus, G. Lenoir, B. Descamps-Latscha |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1999-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1080/09629359990658 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interest of Colchicine for the Treatment of Cystic Fibrosis Patients. Preliminary Report
by: I. Sermet-Gaudelus, et al.
Published: (1999-01-01) -
Advances in the treatment of cystic fibrosis: CFTR modulators
by: Maria Dolores Pastor-Vivero, et al.
Published: (2025-05-01) -
Improvement of intestinal inflammation after treatment with CFTR modulators in cystic fibrosis patients
by: Ruth García Romero, et al.
Published: (2025-05-01) -
The effect of triple CFTR modulator therapy and azithromycin on ion channels and inflammation in cystic fibrosis
by: Suhad Bani Melhim, et al.
Published: (2024-12-01) -
A new era of cystic fibrosis therapy with CFTR modulators
by: Laura Gomes Boabaid de Barros, et al.
Published: (2025-01-01)